Under construction – not a live service
Sign in
Not yet recruitingNo phase

Long-term CPAP Effect with Obstructive Sleep Apnea: a Telemedicine-based

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
National Taiwan University Hospital
Trial code
NCT06738940
Record updated
18 December 2024
Original description
we hypothesize that long-term CPAP could results in increase weight and muscle composite by changing intake content and hormone and the effect was influenced by presence of CVD, social jet lag, and CPAP compliance. The project aims to conduct a telemedicine-based, multicenter, RCTs to compare the effect of 48-week CPAP and usual care on social jet lag, muscular fat, hormone, and attention and memory in 100 participants with moderate-severe OSA.Read full original descriptionShow less

Long-term CPAP Effect on Social Jet Lag, Intake, Muscular Lipid, Hormone, and Cognition in Patients with Obstructive Sleep Apnea: a Telemedicine-based, Multi-center, Randomized Controlled Trial

we hypothesize that long-term CPAP could results in increase weight and muscle composite by changing intake content and hormone and the effect was influenced by presence of CVD, social jet lag, and CPAP compliance. The project aims to conduct a telemedicine-based, multicenter, RCTs to compare the effect of 48-week CPAP and usual care on social jet lag, muscular fat, hormone, and attention and memory in 100 participants with moderate-severe OSA.

Inclusion: age:≧20 year-old; patients with moderate-severe OSA (AHI≥15/hr).

Exclusion: Use anti-inflammatory drugs(in last 2 weeks); has been Spinal Surgery and move difficult; skin allergy; Neurological Disorders(Infection, Stroke, ALS, Myopathy, Brain tumor and Encephalitis); Internal Diseases(cardiovascular disease or coronary artery disease was poorly controlled; chronic heart failure(including NYHA class 3 or more than NYHA class 3); Acromegaly and Parkinson's disease); Psychosis(Schizophrenia, bipolar disorder and depression); Autoimmune disease(System Lupus Erythematosus, Rheumatoid arthritis, Sarcoidosis, Crohn's disease and Ulcerative Colitis); Cancer(in last 5 years); other sleep disorder(Narcolepsy, insomnia and RBD); Chronic Kidney Disease(eGFR<30); wrist tattoos; BMI≧40 kg/m2; COPD(FEV1/FVC<70); Hyperthyroidism or Hypothyroidism; Primary Aldosteronism; Have been diagnosed with obstructive sleep apnea; Illiterate; shift worker; professional driver has severe drowsiness.

ClinicalTrials.gov NCT06738940